Māori Pathways to and Through Health Care for STEMIs in New Zealand. Summer Studentship Research by Ellie Tuzzolino- Smith

Similar documents
Cardiovascular Disease Strategic Action Plan

GENERAL HEART DISEASE KNOW THE FACTS

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

What is a Heart Attack? 1,2,3

URN: Family name: Given name(s): Address:

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

NIHI Big Data in Healthcare Research Case Study

SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

CARDIAC REHABILITATION

The National Service Framework for Cardiac Disease: Strategic Aims and Implementation A Cardiac Work Programme for Wales

The Cardiac Society of Australia and New Zealand

Listen to your heart: Good Cardiovascular Health for Life

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Consultation Draft: Clinical Care Standard for Acute Coronary Syndrome December 2013

Post discharge tariffs in the English NHS

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

HAAD JAWDA Quality KPI; waiting times. December 2015

Heart Center Packages

National Clinical Programmes

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

Coronary Heart Disease (CHD) Brief

Open and Honest Care in your Local Hospital

What are the PH interventions the NHS should adopt?

California Health and Safety Code, Section

Heart Attack: What You Need to Know

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Secondary prevention of cardiovascular disease. A call to action to improve the health of Australians

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Cardiac Clinical Advisory Group Cardiology Services

Cancer research in the Midland Region the prostate and bowel cancer projects

Cardiac Rehab. Home. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

2. Reveal whether the referral process is responsible for introducing any inequalities

Aktuelle Literatur aus der Notfallmedizin

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Main Effect of Screening for Coronary Artery Disease Using CT

DH Cardiac Rehabilitation Commissioning Pack: highlights and process. Prof Patrick Doherty BACR conference Liverpool 2010

Cardiology ARCP Decision Aid August 2014

Appendix i. All-Wales Cardiac Rehabilitation Pathway. All-Wales Cardiac Rehabilitation Group 2009

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Disclosures. The FAST-MI registry is a registry of the French Society of Cardiology, supported by unrestricted grants from:

Prognostic impact of uric acid in patients with stable coronary artery disease

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Nurse Practitioner Role Primary Health Care In General Practice Setting.

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

Heart Attack Your quick guide

The Bioresorbable Vascular Stent Dr Albert Ko

The Swedish approach: Quality Assurance with Clinical Quality Registries the RIKS-HIA example

Monitoring acute coronary syndrome using national hospital data An information paper on trends and issues

Management of Acute Coronary Syndrome / NSTEMI

The Scottish Ambulance Service Improving Care, Reducing Costs. Working together for better patient care

Mission: Lifeline North Texas STEMI Workshop. The Model STEMI Referring Center (non-pci capable) Trisha Wren, RN, BSN

Exploring healthcare variation in Australia

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

THE RISK OF HEART ATTACK IN LONE MOTHERS by Asma Al Bulushi. I had been working as a nurse in the cardiology intensive care unit at Hamad Hospital

The ACC 50 th Annual Scientific Session

Mission: Lifeline EMS Recognition Guide

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators

A PATIENTS GUIDE TO CORONARY ANGIOPLASTY AND STENTING

Service Specification Template Department of Health, updated June 2015

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

September District health board mental health and addictions services

S Hutton, A Inglis, C McKiernan, S Hearns, P Campbell, M Lindsay

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit

Cardiac Rehabilitation

British Cardiovascular Society: Guidance on appropriate workload for consultant cardiologists

Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care

EXAMINATION trial. Manel Sabaté Hospital Clínic, Barcelona (On behalf of the Examination Investigators)

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative

Lifecheque Basic Critical Illness Insurance

POSITION DESCRIPTION

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Primary care management of group A streptococcal pharyngitis in Northland

Karen R. Waters. Advanced Nurse Practitioner and Professor Martin Johnson, University of Salford

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

Overview Of Cardiac Rehabilitation Programs In Malaysia Updates & Innovations

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Cardiac rehabilitation

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

Big data in health research Professor Tony Blakely

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Clinical Study Synopsis

4th Annual New York Stroke Conference Maximizing Stroke Quality of Care: Key Ingredients

Redefining the NSTEACS pathway in London

Ch. 138 CARDIAC CATHETERIZATION SERVICES CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Reflections on the contribution of the Sue Ryder Care Centre to the National End of Life Care Programme

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

CARDIAC REHABILITATION Winnipeg Region Annual Report

Transcription:

Māori Pathways to and Through Health Care for STEMIs in New Zealand Summer Studentship Research by Ellie Tuzzolino- Smith

Terminology & Current Practice STEMI: S-T elevation Myocardial Infarction. Determined with ECG. More sever form of heart attack. Usually caused by blood clot, occluding coronary arteries, often these arteries are smaller than they should be due to arthrosclerosis. CODE STEMI: Protocol at Whangarei Hospital at time of study where patients presenting with STEMI flown by helicopter to Auckland for rescue PCI.

Terminology & Current Practice Rescue PCI: Percutaneous Coronary intervention, cardio angiography performed, clot (if found) is aspirated, vessel is dilated with a balloon and metal stent is placed in any arteries with significantly decreased lumen size. To reduce risk of permanent damage to myocardium needs to occur within 90-120mins from onset of pain (White, 2012). Thrombolysis/ TNK: Tenecteplase, current drug used for alternative intervention in case of STEMI. Dissolves clot that is causing the STEMI. To reduce risk of permanent damage to myocardium needs to occur within 30mins from onset of pain (White, 2012).

Background According to NDHB data, mortality rates from acute myocardial infarction (MI) in Māori in Northland are 3-6 times Non-Māori. In contrast, an initial study of management of STEMI patients in Northland referred for acute angiography and stenting at Auckland hospital showed 79% were Pākehā men (White, 2012).

Aims To determine any inequities in care pathways pre-, during and post-admission between Māori and Non-Māori presenting with STEMI in Northland in 2011-12.

Data retrieved from: Methods The PREDICT primary care database Patient files Concerto (Northland DHB s electronic clinical record system) STEMI audit data and cardiac rehabilitation data. It was collated into a standard format. Analysis of demographic, pre-admission, intra hospital and post-discharge variables was carried out.

Baseline demographics for Northland STEMI patients 2011-2012 Total STEMI patents in 2011-2012: 106 Minus-Out of Northland residence: 99 Minus-Files not pulled before 21/01/2013: 96 Māori (%/n) Non-Māori (%/n) Total 18 78 Males 83.3% (15) 73.1% (57) Females 16.7% (3) 26.9% (21) Median age 58 68 Median Age: Males: 57 Females: 67 Males: 67 Females:68 NZdep Quintile:1&2 11.1% (2) 14.1% (11) 3&4 11.1% (2) 33.3% (26) 5&6 55.6% (10) 24.4% (19) 7&8 0% (0) 15.4% (12) 9&10 22.2% (4) 12.8% (10)

Pre-Hospital Admission Factors Māori (%/n) Non-Māori (%/n) Entered in Predict: 77.8% (14) 44.9% (35) Predict risk >15%: 78.6% (11) 71.4% (11) Predict multiple risk factors 100% (14) 71.4% (11) Predict patients with: Diabetes 64.3% (9) 22.9% (25) Previous MI 21.4% (3) 34.3% (12) Current 57.1% (8) 14.3% (5) Smoker BMI>25 83.3% (10) 75.9% (29) BP > 140/90 28.6% (4) 8.6% (3) Prescribed interventions 72.7% (8) 52% (13)

Annualised STEMI rates. Average of 2011-2012 Māori (rate/100,000/year) 35-49 Years 22.3 18.7 50-74 Years 65.1 64.9 75+ Years 73 105.1 Annualised Myocardial infarction deaths for 2006-2008 Māori (rate/100,000/year) Non-Māori (rate/100,000/year) Non-Māori (rate/100,000/year) 35-49 Years 24.3 7.3 50-74 Years 246.8 53.1 75+ Years 1021.0 737.4 Female Male Female Male 35-49 Years 6.3 46.0 0.0 15.1 50-74 Years 135.4 376.2 22.5 83.3 75+ Years 796.0 1363.6 700.7 781.9

Distances by car

Driving distance from home to hospital Live: Māori (%/n) Non-Māori (%/n) <30min of Hospital 83.3% (15) 64.1% (50) >30min of Hospital 16.7% (3) 35.9% (28) Initial admission factors Admitted to: Māori (%/n) Non-Māori (%/n) Bay of Islands ED 22.2% (4) 6.4% (5) Dargaville ED 5.6% (1) 9% (7) Kaitaia ED 11.1% (2) 9% (7) Rawene ED 0% (0) 1.3% (1) Whangarei ED 61.1% (11) 74.4% (58) Sent by GP/White cross 11.1% (2) 5.1% (4)

Clinical presentation

Treatment Decisions Māori (%/n) Non-Māori (%/n) Pre-ED Thrombolysis 5.6% (1) 11.5% (9) ED Thrombolysis 50% (9) 30.8% (24) CODE STEMI 38.9% (7) 47.4% (37) Non-Urgent 5.6% (1) 6.4% (5) Diagnostic angio 88.9% (16) 88.5% (69) PCI: 55.6% (10) 73.1%(57) Successful Stenting 80% (8) 84.2% (48) Unsuccessful Stent 20% (2) 15.8% (9) Diagnostic ECHO 83.3%(15) 83.3% (60) Pre-ED thrombolysis was more likely to occur if patients lived further than 30 minutes from a hospital, and overall, the CODE STEMI pathway was more likely to be offered to patients living within 30 minutes of Whangārei hosp (both stat sig). The travel time from onset of pain to time of call to GP/ambulance is of no difference between Maori and non-maori.

Total STEMI patients mortality Māori (%/n) Non-Māori (%/n) Deceased before discharge 0% (0) 7.7% (6) Deceased before outpatient appt. Deceased within 6months STEMI 5.6% (1) 11.5% (9) 11.1% (2) 11.5% (9) Mortality Thrombolysis patients vs PCI Of the 2 Māori who died, both had been sent for CODE STEMI and had succesful PCI. Of the 9 Non-Māori who died, 3 went for CODE STEMI but had unsuccessful PCI 3 had thrombolysis only 2 had thrombolysis followed by unsuccesful PCI 1 refused treatment

Post STEMI follow up Māori (%/n) Non-Māori (%/n) Have Outpatient records 76.5% (13) 87% (60) Reported follow up ECHO: 27.8% (5) 32.9% (24) Reported follow up ETT: 5.9% (1) 11.6% (7) Cardiac Monitoring Test: 0% (0) 5.8% (4) Offered cardiac rehab: 82.4% (14) 84.1% (58) Attended (of Offered): 35.7% (5) 55.2% (32) ECHO: Echocardiogram (Cardiac Ultrasound) ETT: Exercise tolerance test (done on treadmill hooked up to ECG)

Discussion 1) Only 18/96 were Māori of these most were entered in predict and most lived within 30minutes of the hospital, indicating that this group was not reflective of true Māori population. This group may face less barriers to health care and further investigation must be done into what barriers the unrepresented Māori are facing to health care.

2)There are inequities that need to be addressed, in terms of geographical access to CVD and STEMI management in Northland. Wider availability of treadmill testing and angiography, and systematic use of pre-ed thrombolysis may have a greater impact on patient outcomes than putting more effort into the CODE STEMI pathway. Further research is also needed to assess and address barriers for Māori to primary care, CVD risk assessment and management.

3)However there were no statistically significant inequities identified in the pathway of care between Māori and Non-Māori in this study, once STEMI was diagnosed, the mortality outcomes were similar. Geographical proximity to Whangārei hospital (<30mins by road) was the primary determinant of whether patients followed the CODE STEMI protocol rather than whether they were Māori or Non-Māori.

Strengths of this study Looking directly at patient files enabled a greater depth of knowledge to be gained. Opportunity for further analysis as medication data was also obtained. Weaknesses Information on modes of transport to the hospital would have been helpful in analysing timing and distance and should have been recorded during file data collection.

Opportunity for further research Gain ethics approval to look at if each STEMI patient was filling their medication scripts post STEMI. More qualitative research is needed to determine further, the barriers Māori are facing to CVD prevention and management and how they can be addressed, so that CVD inequities can be diminished. For example issues around health literacy, GP services and emergency transport in a more rural setting could be investigated further. Along with whether Māori want to go to hospital.

Acknowledgements Drs Clair Mills, Kyle Eggleton and Stephen Jennison: Supervisors Anil Shetty: Mapping, Technical support Ryan Howard & Sue Vallancey: STEMI Audit Data Stephen Jennison, Wendy Coleman & Lorraine Parker: Cardiac Rehabilitation Data Medical Records Staff: File Retrieval Pukawakawa Staff and Program: Facility Usage Northland DHB: Facility usage and creating the opportunity to carry out this study. University of Auckland: Funders of the Studentship programme.

Summer Studentship, How recruited. personal experience Māori students doing Māori research, will get funding. Jobs I did. What I enjoyed: Meeting people, seeing how DHBs work, Analysis, living at home. What I found challenging: Data collection, understanding statistics.